Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Re-epithelialization of Diabetic Skin and Mucosal Wounds is Rescued by Treatment with Epigenetic Inhibitors

Bo Yang, Stella Alimperti, Michael V. Gonzalez, Tzvete Dentchev, Minjung Kim, Justin Suh, Paul M. Titchenell, Kang I. Ko, John Seykora, Manju Benakanakere, Dana T. Graves

Diabetes db230258

https://doi.org/10.2337/db23-0258

Published: 24 October 2023

View article titled, Re-epithelialization of Diabetic Skin and Mucosal Wounds is Rescued by Treatment with Epigenetic Inhibitors

Meeting Abstracts

824-P: Glycemic Improvement, Insulin Reductions, and Improved Body Weight 48 Weeks after Revita Duodenal Mucosal Resurfacing in T2D patients with Previously Inadequately Controlled Glucose Despite Multiple Glucose-Lowering Agents Including Insulin

VIVIAN FONSECA, JACQUES BERGMAN, ZEB I. SAEED, HARITH RAJAGOPALAN, BARBARA SORONDO, KELLY WHITE, HUI ZHANG, GELTRUDE MINGRONE

Diabetes 2023;72(Supplement_1):824-P

https://doi.org/10.2337/db23-824-P

Published: 20 June 2023

View article titled, 824-P: Glycemic Improvement, Insulin Reductions, and Improved Body Weight 48 Weeks after Revita Duodenal Mucosal Resurfacing in T2D patients with Previously Inadequately Controlled Glucose Despite Multiple Glucose-Lowering Agents Including Insulin

Journal Articles

Erratum. Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds. Diabetes 2015;64:243–256

Fanxing Xu, Badr Othman, Jason Lim, Angelika Batres, Bhaskar Ponugoti, Chenying Zhang, Leah Yi, Jian Liu, Chen Tian, Alhassan Hameedaldeen, Sarah Alsadun, Rohinton Tarapore, Dana T. Graves

Diabetes 2022;71(11):2458

https://doi.org/10.2337/db22-er11a

Published: 30 August 2022

View article titled, Erratum. Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds. Diabetes 2015;64:243–256

Meeting Abstracts

1405-P: Bacteroides thetaiotaomicron Fortifies the Gut Mucosa and Improves Host Metabolism in Dietary Obese Mice

JENNIFER LEE, KERRY WELLENSTEIN, BARBARA B. KAHN

Diabetes 2022;71(Supplement_1):1405-P

https://doi.org/10.2337/db22-1405-P

Published: 01 June 2022

View article titled, 1405-P: Bacteroides thetaiotaomicron Fortifies the Gut Mucosa and Improves Host Metabolism in Dietary Obese Mice

Meeting Abstracts

1670-P: Enalapril Maleate, Angiotensin-Converting Enzyme Inhibitor, Suppresses the Expression of the MHC Molecules in Mucosal Cells of the Small Intestine Leading to the Delayed Onset of Autoimmune Type 1 Diabetes Mellitus in NOD Mice

MASAKAZU HATTORI, AIKO UEDA, RYUICHI KATOH, MASATAKA HIRAI, AKIHIRO NODA, KAZUYA MAYANAGI, YOSHITO FURUICHI, KIMIE HATTORI, TORBEN LUND, KENJI KOBAYASHI, YASUYUKI NAKAMURA

Diabetes 2020;69(Supplement_1):1670-P

https://doi.org/10.2337/db20-1670-P

Published: 01 June 2020

View article titled, 1670-P: Enalapril Maleate, Angiotensin-Converting Enzyme Inhibitor, Suppresses the Expression of the MHC Molecules in Mucosal Cells of the Small Intestine Leading to the Delayed Onset of Autoimmune Type 1 Diabetes Mellitus in NOD Mice

Meeting Abstracts

1662-P: Lower Expression of Bile Acid Transporters and Fibroblast Growth Factor 19 in Mucosa Biopsies from the Ileocecal Region in Persons with Type 2 Diabetes Compared with Healthy Controls

HENRIETTE H. NERILD, ANDREAS BRØNDEN, ABDULLAH EL HADDOUCHI, TINA JORSAL, DAVID P. SONNE, JACOB JELSING, KRISTOFFER RIGBOLT, TINA VILSBØLL, FILIP K. KNOP

Diabetes 2020;69(Supplement_1):1662-P

https://doi.org/10.2337/db20-1662-P

Published: 01 June 2020

View article titled, 1662-P: Lower Expression of Bile Acid Transporters and Fibroblast Growth Factor 19 in Mucosa Biopsies from the Ileocecal Region in Persons with Type 2 Diabetes Compared with Healthy Controls

Meeting Abstracts

1905-P: Downregulation of HMGCS2 Expression in Small Intestinal Mucosa Biopsies after Roux-en-Y Gastric Bypass Surgery: A Possible Contributor to GLP-1 Hypersecretion?

CHRISTIAN LEGART, TINA JORSAL, CHRISTOFFER A. HAGEMANN, DORTE WORM, CLAUS B. JUHL, ALIN R. ANDRIES, CHEN ZHANG, NIELS VRANG, KRISTOFFER RIGBOLT, JACOB JELSING, TINA VILSBØLL, FILIP K. KNOP

Diabetes 2020;69(Supplement_1):1905-P

https://doi.org/10.2337/db20-1905-P

Published: 01 June 2020

View article titled, 1905-P: Downregulation of HMGCS2 Expression in Small Intestinal Mucosa Biopsies after Roux-en-Y Gastric Bypass Surgery: A Possible Contributor to GLP-1 Hypersecretion?

Meeting Abstracts

121-LB: Durable Glycemic Improvements after Duodenal Mucosal Resurfacing (DMR) in Patients with Type 2 Diabetes (T2D): 48-Week Results from the REVITA-2 European Cohort

GELTRUDE MINGRONE, DAVID HOPKINS, GURUPRASAD AITHAL, GUIDO COSTAMAGNA, LAURENT CRENIER, JACQUES M. DEVIERE, RUSSELL DRUMMOND, REHAN HAIDRY, ISKANDAR R. I, ANDREA LANIA, CORMAC MAGEE, MAX NIEUWDORP, VIJETA BHAMBHANI, JASON HUANG, KELLY WHITE, JUAN CARLOS LOPEZ-TALAVERA, HARITH RAJAGOPALAN, JACQUES J. BERGMAN

Diabetes 2020;69(Supplement_1):121-LB

https://doi.org/10.2337/db20-121-LB

Published: 01 June 2020

View article titled, 121-LB: Durable Glycemic Improvements after Duodenal Mucosal Resurfacing (DMR) in Patients with Type 2 Diabetes (T2D): 48-Week Results from the REVITA-2 European Cohort

Journal Articles

Polysaccharide A–Dependent Opposing Effects of Mucosal and Systemic Exposures to Human Gut Commensal Bacteroides fragilis in Type 1 Diabetes

M. Hanief Sofi, Benjamin M. Johnson, Radhika R. Gudi, Amy Jolly, Marie-Claude Gaudreau, Chenthamarakshan Vasu

Diabetes 2019;68(10):1975–1989

https://doi.org/10.2337/db19-0211

Published: 16 July 2019

View article titled, Polysaccharide A–Dependent Opposing Effects of Mucosal and Systemic Exposures to Human Gut Commensal Bacteroides fragilis in Type 1 Diabetes

Includes: Supplementary data

Meeting Abstracts

1156-P: Duodenal Mucosal Resurfacing (DMR) Combined with GLP-1 RA May Eliminate Insulin Therapy and Improve Metabolic Health in Type 2 Diabetes

PAUL SMEELE, ANNIEKE C. VAN BAAR, TESSA M. VRIEND, FRITS HOLLEMAN, MAARTEN SOETERS, MAX NIEUWDORP, JAN TIJSSEN, JACQUES J. BERGMAN

Diabetes 2019;68(Supplement_1):1156-P

https://doi.org/10.2337/db19-1156-P

Published: 01 June 2019

View article titled, 1156-P: Duodenal Mucosal Resurfacing (DMR) Combined with GLP-1 RA May Eliminate Insulin Therapy and Improve Metabolic Health in Type 2 Diabetes

Meeting Abstracts

Duodenal Mucosal Resurfacing Elicits Improvement in Glycemic and Hepatic Parameters in Type 2 Diabetes—One-Year Multicenter Study Results

ANNIEKE C.G. VAN BAAR, MAX NIEUWDORP, FRITS HOLLEMAN, JACQUES DEVIERE, LAURENT CRENIER, REHAN HAIDRY, RACHEL L. BATTERHAM, DAVID HOPKINS, LEONARDO RODRIGUEZ GRUNERT, MANOEL GALVAO NETO, PAULINA VIGNOLO, GUIDO COSTAMAGNA, JACQUES J. BERGMAN

Diabetes 2018;67(Supplement_1):1137-P

https://doi.org/10.2337/db18-1137-P

Published: 01 July 2018

View article titled, Duodenal Mucosal Resurfacing Elicits Improvement in Glycemic and Hepatic Parameters in Type 2 Diabetes—One-Year Multicenter Study Results

Meeting Abstracts

Mucosal Gamma/Delta T Cells Increased by i.n. Administration of Gliadin to Four-Week-Old NOD Mice Prevent Diabetes in the NOD-SCID Model of Adoptive Cotransfer of Diabetes

DAVID FUNDA, JAROSLAV GOLIAS, MARTIN HAUPT-JORGENSEN, KARSTEN BUSCHARD

Diabetes 2018;67(Supplement_1):1738-P

https://doi.org/10.2337/db18-1738-P

Published: 01 July 2018

View article titled, Mucosal Gamma/Delta T Cells Increased by i.n. Administration of Gliadin to Four-Week-Old NOD Mice Prevent Diabetes in the NOD-SCID Model of Adoptive Cotransfer of Diabetes

Journal Articles

Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models

Sarah Forbes, Stuart Stafford, Gareth Coope, Helen Heffron, Katia Real, Robert Newman, Richard Davenport, Matt Barnes, Johannes Grosse, Helen Cox

Diabetes 2015;64(11):3763–3771

https://doi.org/10.2337/db15-0481

Published: 03 August 2015

View article titled, Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models

Includes: Supplementary data

Journal Articles

An Innate Disposition for a Healthier Gut: GLP-1R Signaling in Intestinal Epithelial Lymphocytes

Wilfredo Rosario, David D’Alessio

Diabetes 2015;64(7):2329–2331

https://doi.org/10.2337/db15-0436

Published: 17 June 2015

View article titled, An Innate Disposition for a Healthier Gut: GLP-1R Signaling in Intestinal Epithelial Lymphocytes

Journal Articles

In This Issue of Diabetes

Diabetes 2015;64(1):1–2

https://doi.org/10.2337/db15-ti01

Published: 16 December 2014

View article titled, In This Issue of Diabetes

Journal Articles

Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds

Fanxing Xu, Badr Othman, Jason Lim, Angelika Batres, Bhaskar Ponugoti, Chenying Zhang, Leah Yi, Jian Liu, Chen Tian, Alhassan Hameedaldeen, Sarah Alsadun, Rohinton Tarapore, Dana T. Graves

Diabetes 2015;64(1):243–256

https://doi.org/10.2337/db14-0589

Published: 03 September 2014

View article titled, Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds

Includes: Supplementary data

Journal Articles

Type 1 Diabetes Is Associated With Enterovirus Infection in Gut Mucosa

Maarit Oikarinen, Sisko Tauriainen, Sami Oikarinen, Teemu Honkanen, Pekka Collin, Immo Rantala, Markku Mäki, Katri Kaukinen, Heikki Hyöty

Diabetes 2012;61(3):687–691

https://doi.org/10.2337/db11-1157

Published: 13 February 2012

View article titled, Type 1 Diabetes Is Associated With Enterovirus Infection in Gut Mucosa

Includes: Supplementary data

Journal Articles

Defective Differentiation of Regulatory FoxP3⁺ T Cells by Small-Intestinal Dendritic Cells in Patients With Type 1 Diabetes

Ester Badami, Chiara Sorini, Margherita Coccia, Vera Usuelli, Laura Molteni, Andrea Mario Bolla, Marina Scavini, Alberto Mariani, Cecile King, Emanuele Bosi, Marika Falcone

Diabetes 2011;60(8):2120–2124

https://doi.org/10.2337/db10-1201

Published: 18 July 2011

View article titled, Defective Differentiation of Regulatory FoxP3+ T Cells by Small-Intestinal Dendritic Cells in Patients With Type 1 Diabetes

Includes: Supplementary data

Journal Articles

Resistin-Like Molecule-β Inhibits SGLT-1 Activity and Enhances GLUT2-Dependent Jejunal Glucose Transport

Rim Belharbi Krimi, Philippe Letteron, Pia Chedid, Corinne Nazaret, Robert Ducroc, Jean-Claude Marie

Diabetes 2009;58(9):2032–2038

https://doi.org/10.2337/db08-1786

Published: 05 June 2009

View article titled, Resistin-Like Molecule-β Inhibits SGLT-1 Activity and Enhances GLUT2-Dependent Jejunal Glucose Transport

Journal Articles

Luminal Leptin Induces Rapid Inhibition of Active Intestinal Absorption of Glucose Mediated by Sodium-Glucose Cotransporter 1

Robert Ducroc, Sandra Guilmeau, Khalil Akasbi, Hélène Devaud, Marion Buyse, André Bado

Diabetes 2005;54(2):348–354

https://doi.org/10.2337/diabetes.54.2.348

Published: 01 February 2005

View article titled, Luminal Leptin Induces Rapid Inhibition of Active Intestinal Absorption of Glucose Mediated by Sodium-Glucose Cotransporter 1

NARROW

Re-epithelialization of Diabetic Skin and Mucosal Wounds is Rescued by Treatment with Epigenetic Inhibitors

824-P: Glycemic Improvement, Insulin Reductions, and Improved Body Weight 48 Weeks after Revita Duodenal Mucosal Resurfacing in T2D patients with Previously Inadequately Controlled Glucose Despite Multiple Glucose-Lowering Agents Including Insulin

Erratum. Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds. Diabetes 2015;64:243–256

1405-P: Bacteroides thetaiotaomicron Fortifies the Gut Mucosa and Improves Host Metabolism in Dietary Obese Mice

1670-P: Enalapril Maleate, Angiotensin-Converting Enzyme Inhibitor, Suppresses the Expression of the MHC Molecules in Mucosal Cells of the Small Intestine Leading to the Delayed Onset of Autoimmune Type 1 Diabetes Mellitus in NOD Mice

1662-P: Lower Expression of Bile Acid Transporters and Fibroblast Growth Factor 19 in Mucosa Biopsies from the Ileocecal Region in Persons with Type 2 Diabetes Compared with Healthy Controls

1905-P: Downregulation of HMGCS2 Expression in Small Intestinal Mucosa Biopsies after Roux-en-Y Gastric Bypass Surgery: A Possible Contributor to GLP-1 Hypersecretion?

121-LB: Durable Glycemic Improvements after Duodenal Mucosal Resurfacing (DMR) in Patients with Type 2 Diabetes (T2D): 48-Week Results from the REVITA-2 European Cohort

Polysaccharide A–Dependent Opposing Effects of Mucosal and Systemic Exposures to Human Gut Commensal Bacteroides fragilis in Type 1 Diabetes

1156-P: Duodenal Mucosal Resurfacing (DMR) Combined with GLP-1 RA May Eliminate Insulin Therapy and Improve Metabolic Health in Type 2 Diabetes

Duodenal Mucosal Resurfacing Elicits Improvement in Glycemic and Hepatic Parameters in Type 2 Diabetes—One-Year Multicenter Study Results

Mucosal Gamma/Delta T Cells Increased by i.n. Administration of Gliadin to Four-Week-Old NOD Mice Prevent Diabetes in the NOD-SCID Model of Adoptive Cotransfer of Diabetes

Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models

An Innate Disposition for a Healthier Gut: GLP-1R Signaling in Intestinal Epithelial Lymphocytes

In This Issue of Diabetes

Foxo1 Inhibits Diabetic Mucosal Wound Healing but Enhances Healing of Normoglycemic Wounds

Type 1 Diabetes Is Associated With Enterovirus Infection in Gut Mucosa

Defective Differentiation of Regulatory FoxP3⁺ T Cells by Small-Intestinal Dendritic Cells in Patients With Type 1 Diabetes

Resistin-Like Molecule-β Inhibits SGLT-1 Activity and Enhances GLUT2-Dependent Jejunal Glucose Transport

Luminal Leptin Induces Rapid Inhibition of Active Intestinal Absorption of Glucose Mediated by Sodium-Glucose Cotransporter 1

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only